Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 2566

Sort by

Sort Order Select

Journal Articles

Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma

James K. Godfrey, Lei Gao, Geoffrey Shouse, Joo Y. Song, Stacy Pak, Brian Lee, Bihong T. Chen, Avyakta Kallam, John H. Baird, Guido Marcucci, Lucy Ghoda, Stephanie Vauleon, Alexey V. Danilov, Alex F. Herrera, Larry W. Kwak, Lihua E. Budde

Blood (2024) 144 (4): 457–461.

https://doi.org/10.1182/blood.2024024168

Published: 2024

Includes: Supplemental data

Journal Articles

Ibrutinib as part of risk-stratified treatment for posttransplant lymphoproliferative disorder: the phase 2 TIDaL trial

Blood (2024) 144 (4): 392–401.

https://doi.org/10.1182/blood.2024023847

Published: 2024

Includes: Supplemental data

Journal Articles

Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma

Blood (2024) 144 (4): 402–407.

https://doi.org/10.1182/blood.2023023557

Published: 2024

Includes: Supplemental data

Journal Articles

EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma

Blood (2024) 144 (4): 359–367.

https://doi.org/10.1182/blood.2024024371

Published: 2024

Includes: Supplemental data

Journal Articles

Pseudo-Chédiak-Higashi inclusions in a low-grade lymphoid neoplasm

Margaryta Stoieva, Keenan Hogan

Blood (2024) 144 (4): 462.

https://doi.org/10.1182/blood.2024024419

Published: 2024

Journal Articles

KDM6A Regulates Immune Response Genes in Multiple Myeloma

Daphne Dupere-Richer, Alberto Riva, Benjamin G Barwick, Sayantan Maji, Heidi Casellas Roman, Jianping Li, Umasankar De, Amin Sobh, Gabrielle Quickstad, Crissandra Piper, Marta Kulis, Teresa Ezponda, José-Ignacio Ignacio Martín-Subero, Giovanni Tonon, Weizhou Zhang, Constantine S. Mitsiades, Lawrence H Boise, Richard L Bennett, Jonathan D Licht

Blood blood.2024024518.

https://doi.org/10.1182/blood.2024024518

Published: 2024

Includes: Supplemental data

Journal Articles

How I treat post-immunotherapy relapsed B-ALL

Adam J. Lamble, Alexandra E Kovach, Nirali N Shah

Blood blood.2024024517.

https://doi.org/10.1182/blood.2024024517

Published: 2024

Journal Articles

NSD2 drives t(4;14) myeloma cell dependence on adenylate kinase 2 by diverting one-carbon metabolism to the epigenome

Blood (2024) 144 (3): 283–295.

https://doi.org/10.1182/blood.2023022859

Published: 2024

Includes: Supplemental data

Journal Articles

Acalabrutinib, venetoclax, and obinutuzumab in relapsed/refractory CLL: final efficacy and ctDNA analysis of the CLL2-BAAG trial

Blood (2024) 144 (3): 272–282.

https://doi.org/10.1182/blood.2023022730

Published: 2024

Includes: Supplemental data

Journal Articles

Efficacy of CAR T-cell therapy is not impaired by previous bispecific antibody treatment in large B-cell lymphoma

Blood (2024) 144 (3): 334–338.

https://doi.org/10.1182/blood.2024024526

Published: 2024

Includes: Supplemental data

Journal Articles

Obinutuzumab vs rituximab for transplant-eligible patients with mantle cell lymphoma

Blood (2024) 144 (3): 262–271.

https://doi.org/10.1182/blood.2024023944

Published: 2024

Includes: Supplemental data

Journal Articles

How I use next-generation sequencing–MRD to plan approach and prevent relapse after HCT for children and adults with ALL

Lori Muffly, Emily C. Liang, J. Gregory Dolan, Michael A. Pulsipher

Blood (2024) 144 (3): 253–261.

https://doi.org/10.1182/blood.2023023699

Published: 2024

Journal Articles

Double-hit, double-expressor follicular lymphoma with plasmacytic differentiation

Hibbah Nabeel, Govind Bhagat

Blood (2024) 144 (3): 339.

https://doi.org/10.1182/blood.2024023881

Published: 2024

Journal Articles

Pediatric T-cell lymphoblastic lymphoma but not leukemia harbor TRB::NOTCH1 fusions with unfavorable outcome

Blood blood.2024025307.

https://doi.org/10.1182/blood.2024025307

Published: 2024

Includes: Supplemental data

Journal Articles

Antibody-drug conjugate adverse effects can be understood and addressed based on immune complex clearance mechanisms

Ronald P. Taylor, Margaret A. Lindorfer

Blood (2024) 144 (2): 137–144.

https://doi.org/10.1182/blood.2024024442

Published: 2024

Journal Articles

IL-18-secreting multiantigen targeting CAR T cells eliminate antigen-low myeloma in an immunocompetent mouse model

Brandon D. Ng, Adhithi Rajagopalan, Anastasia I. Kousa, Jacob S. Fischman, Sophia Chen, Alyssa Massa, Harold K. Elias, Dylan Manuele, Michael Galiano, Andri L. Lemarquis, Alexander P. Boardman, Susan DeWolf, Jonah Pierce, Bjarne Bogen, Scott E. James, Marcel R. M. van den Brink

Blood (2024) 144 (2): 171–186.

https://doi.org/10.1182/blood.2023022293

Published: 2024

Includes: Supplemental data

Journal Articles

SOX11 expression is restricted to EBV-negative Burkitt lymphoma and is associated with molecular genetic features

Blood (2024) 144 (2): 187–200.

https://doi.org/10.1182/blood.2023023242

Published: 2024

Includes: Supplemental data

Journal Articles

RAS/RAF landscape in monoclonal plasma cell conditions

Blood (2024) 144 (2): 201–205.

https://doi.org/10.1182/blood.2023022295

Published: 2024

Includes: Supplemental data

Journal Articles

Mantle cell lymphoma with IRTA1 + reactive expansion of the marginal zone

Brunangelo Falini, Stefano Lazzi

Blood (2024) 144 (2): 237.

https://doi.org/10.1182/blood.2024024808

Published: 2024

Journal Articles

Single-cell genomics details the maturation block in BCP-ALL and identifies therapeutic vulnerabilities in DUX4-r cases

Hanna Thorsson, Rasmus Henningsson, Noelia Puente-Moncada, Pablo Peña-Martínez, Ludvig Sjöström, Helena Ågerstam, Carl Sandén, Marianne Rissler, Anders Castor, Hanne Vibeke Hansen Marquart, Signe Modvig, Kajsa Paulsson, Cornelis Jan Pronk, Kjeld Schmiegelow, Axel Hyrenius-Wittsten, Christina Orsmark-Pietras, Henrik Lilljebjörn, Thoas Fioretos

Blood blood.2023021705.

https://doi.org/10.1182/blood.2023021705

Published: 2024

Includes: Supplemental data

NARROW

Glofitamab stimulates immune cell infiltration of CNS tumors and induces clinical responses in secondary CNS lymphoma

Ibrutinib as part of risk-stratified treatment for posttransplant lymphoproliferative disorder: the phase 2 TIDaL trial

Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma

EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma

Pseudo-Chédiak-Higashi inclusions in a low-grade lymphoid neoplasm

KDM6A Regulates Immune Response Genes in Multiple Myeloma

How I treat post-immunotherapy relapsed B-ALL

NSD2 drives t(4;14) myeloma cell dependence on adenylate kinase 2 by diverting one-carbon metabolism to the epigenome

Acalabrutinib, venetoclax, and obinutuzumab in relapsed/refractory CLL: final efficacy and ctDNA analysis of the CLL2-BAAG trial

Efficacy of CAR T-cell therapy is not impaired by previous bispecific antibody treatment in large B-cell lymphoma

Obinutuzumab vs rituximab for transplant-eligible patients with mantle cell lymphoma

How I use next-generation sequencing–MRD to plan approach and prevent relapse after HCT for children and adults with ALL

Double-hit, double-expressor follicular lymphoma with plasmacytic differentiation

Pediatric T-cell lymphoblastic lymphoma but not leukemia harbor TRB::NOTCH1 fusions with unfavorable outcome

Antibody-drug conjugate adverse effects can be understood and addressed based on immune complex clearance mechanisms

IL-18-secreting multiantigen targeting CAR T cells eliminate antigen-low myeloma in an immunocompetent mouse model

SOX11 expression is restricted to EBV-negative Burkitt lymphoma and is associated with molecular genetic features

RAS/RAF landscape in monoclonal plasma cell conditions

Mantle cell lymphoma with IRTA1 + reactive expansion of the marginal zone

Single-cell genomics details the maturation block in BCP-ALL and identifies therapeutic vulnerabilities in DUX4-r cases

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only